Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab

Blood
Halvard BonigThalia Papayannopoulou

Abstract

Blockade of CD49d-mediated lymphocyte trafficking has been used therapeutically for certain autoimmune diseases, such as multiple sclerosis (MS). In addition to negative effects on the trafficking of mature lymphocytes to sites of inflammation, CD49d blockade in mice and monkeys rapidly mobilizes hematopoietic stem/progenitor cells (HSPCs) capable of short- and long-term engraftment. Here we aimed to ascertain the effects of treatment with antifunctional anti-CD49d antibody in humans (MS patients receiving infusions of the CD49d-blocking antibody natalizumab) on levels of circulating HSPCs after a single dose of antibody or after long-term treatment. On average, 6-fold elevated levels of circulating CD34+ cells and colony-forming unit-culture (CFU-C) were achieved within 1 day of the first dose of natalizumab, and similar levels were continuously maintained under monthly natalizumab infusions. The blood of natalizumab-treated subjects also contained SCID-repopulating cells. The fate of these circulating HSPCs and their clinical relevance for MS patients remains to be determined.

References

Jun 1, 1979·Biulleten' eksperimental'noĭ biologii i meditsiny·I L ChertkovG A Udalov
Jan 1, 1994·Methods in Cell Biology·Z Darzynkiewicz
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·T Papayannopoulou, B Nakamoto
Aug 11, 2001·Bone Marrow Transplantation·R K BurtP A McSweeney
Dec 4, 2003·Molecular and Cellular Biology·Linda M ScottThalia Papayannopoulou
Sep 29, 2005·Nature Neuroscience·Richard M Ransohoff
Sep 23, 2006·The New England Journal of Medicine·Volker SchächingerUNKNOWN REPAIR-AMI Investigators
Oct 4, 2007·Annals of the New York Academy of Sciences·Helena MareckovaIvan Sterzl

❮ Previous
Next ❯

Citations

Dec 30, 2011·Inflammopharmacology·Saskia Thomas, Daniel C Baumgart
Apr 20, 2010·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Leslie J Marshall, Eugene O Major
Oct 19, 2013·Current Neurology and Neuroscience Reports·Joshua J Chalkley, Joseph R Berger
Mar 31, 2010·International Journal of Hematology·Yoichi ImaiMineo Kurokawa
Nov 30, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Harold L Atkins, Mark S Freedman
Aug 11, 2010·Bone Marrow Transplantation·H Atkins
Mar 23, 2010·Bone Marrow Transplantation·P A RamirezC G Brunstein
Sep 7, 2012·Leukemia·H Bonig, T Papayannopoulou
Mar 23, 2010·Nature Reviews. Drug Discovery·Trevor T HanselAndrew J T George
Dec 19, 2009·The New England Journal of Medicine·Leonid GorelikAlfred W Sandrock
Sep 11, 2009·The New England Journal of Medicine·Eugene O Major
Mar 7, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·Clemens WarnkeAnna Fogdell-Hahn
Jun 13, 2009·Blood·Camille N Abboud
Jan 31, 2014·Blood Reviews·Rusudan K Hopman, John F DiPersio
May 6, 2010·Current Opinion in Neurology·Andreas P Lysandropoulos, Renaud A Du Pasquier
Nov 19, 2010·Expert Review of Hematology·Lloyd E Damon, Lauren E Damon
Mar 2, 2013·Expert Review of Neurotherapeutics·Annika DeißMathias Buttmann
Dec 14, 2011·Expert Review of Clinical Immunology·Maria Chiara G Monaco, Eugene O Major
Jul 2, 2009·Expert Opinion on Biological Therapy·Frank NeumannRainer Haas
Oct 24, 2015·Cellular and Molecular Life Sciences : CMLS·Maria De GrandisMichel Aurrand-Lions
Feb 20, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·R A GroveO Graff
Sep 12, 2015·European Journal of Immunology·Guillaume Martin-BlondelRoland Liblau
Jun 5, 2012·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Claudia SieversRaija L P Lindberg
Sep 17, 2011·Pathology·L Bik ToIan D Lewis
May 10, 2011·Journal of Neuroimmunology·Mario SkaricaPeter A Calabresi
Jan 5, 2011·Neurología : publicación oficial de la Sociedad Española de Neurología·A Horga, M Tintoré
Dec 30, 2015·Annals of the New York Academy of Sciences·Melissa van PelKoen Schepers
Jun 16, 2010·Experimental Neurology·Joanne L Jones, Alasdair J Coles

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.